AMRI's new CEO looking to buy competitors By: Albany Business Review via Business Journals February 13, 2014 at 07:15 AM EST Bill Marth is going shopping--and that says a lot about the turnaround happening at the company he runs, Albany Molecular Research Inc... Read More >> Related Stocks: Teva Pharmaceutical Industries ADR
